- Report
- July 2024
- 120 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3552EUR$4,000USD£3,104GBP
- Report
- May 2023
- 450 Pages
Global
From €3552EUR$4,000USD£3,104GBP
€4439EUR$5,000USD£3,879GBP
- Report
- December 2024
- 200 Pages
Global
From €3330EUR$3,750USD£2,910GBP
- Report
- December 2024
- 200 Pages
Global
From €3330EUR$3,750USD£2,910GBP
- Report
- October 2024
- 200 Pages
Global
From €3330EUR$3,750USD£2,910GBP
- Report
- May 2024
- 200 Pages
Global
From €3685EUR$4,150USD£3,220GBP
- Report
- May 2024
- 200 Pages
Global
From €3685EUR$4,150USD£3,220GBP
- Report
- August 2023
- 145 Pages
Global
From €2797EUR$3,150USD£2,444GBP
- Report
- July 2023
- 145 Pages
Global
From €2797EUR$3,150USD£2,444GBP
- Report
- January 2024
- 95 Pages
Africa, Middle East
From €3063EUR$3,450USD£2,677GBP
- Report
- December 2023
- 150 Pages
Global
From €3951EUR$4,450USD£3,453GBP
From €3063EUR$3,450USD£2,677GBP
- Report
- December 2023
- 140 Pages
Global
From €3951EUR$4,450USD£3,453GBP
- Report
- April 2023
- 120 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- July 2024
- 171 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- September 2023
- 115 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- May 2023
- 120 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- August 2024
- 200 Pages
Global
From €4394EUR$4,949USD£3,840GBP
- Report
- April 2023
- 147 Pages
Global
From €4394EUR$4,949USD£3,840GBP

The CAS9 market is a subset of the genomics industry that focuses on the development and use of the CRISPR-Cas9 gene-editing technology. This technology is used to modify the genetic code of living organisms, allowing for the manipulation of genes and the potential to create new treatments for diseases. CAS9 is a powerful tool for researchers, allowing them to make precise changes to the genetic code of organisms.
The CAS9 market is growing rapidly, with many companies investing in the technology and its applications. Companies such as Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences are leading the way in developing and commercializing the technology. Other companies such as Horizon Discovery, Synthego, and Twist Bioscience are also investing in the CAS9 market, providing tools and services to researchers. Show Less Read more